Company & Sponsor Intelligence

King's College London

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials12

Recruiting3

Completed5

Countries3

Therapeutic footprint

adhdautismeating_disordersepilepsyother_psychiatryparkinsonssubstance_use

Indexed studies

NCT05301673ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence
adhd · SpainACTIVE_NOT_RECRUITING

NCT05383300Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy
other_psychiatry · United KingdomNA

NCT04007718Learning Effective New Strategies for Worry in Parkinson's Disease
parkinsons · United KingdomNA

NCT03126526A Multimodal Outcome Study of Eating Disorders
eating_disorders · United KingdomNA

NCT06144047Real World Testing and Cost-effectiveness Analysis of Subcutaneous EEG
epilepsy · United KingdomNA

NCT04958655Mental Imagery Intervention for Alcohol Craving
substance_use · United KingdomNA

NCT07228650ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes
adhd · United KingdomRECRUITING

NCT04145076Brain Response to Serotonergic Medications in ASD
autism · United KingdomNA

NCT06537895Eating Disorders Clinical Research Network
eating_disorders · NOT_YET_RECRUITING

NCT06072287The Living With a Long-Term Condition Study
parkinsons · United KingdomUNKNOWN

NCT00282854Genetics of Rolandic Epilepsy
epilepsy · United StatesCOMPLETED

NCT04494594Drinks:Ration - Combat Stress Randomized Controlled Trial
substance_use · United KingdomNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →